Welltower (WELL)
Real Estate · Healthcare REIT · NYSE
Welltower is a premier healthcare real estate investment trust providing the infrastructure for the aging population's care needs through its extensive portfolio of seniors housing and post-acute facilities.
What Welltower does
Welltower is a real estate investment trust (REIT) that invests in healthcare infrastructure, specifically focusing on seniors housing, post-acute care, and outpatient medical properties. The company operates through a portfolio of properties that are managed by third-party operators or through RIDEA-structured arrangements, providing a range of care levels from independent living to skilled nursing. Welltower's business model relies on the ongoing demand for healthcare services for the aging population and the associated real estate requirements.
Themes: seniors housing, healthcare infrastructure, aging population, assisted living, post-acute care, outpatient medical
Fundamentals
- Price$239.22 as of 2026-08-21 close
- Market cap$168.9B as of 2026-08-21
- 1-year return+43.3% 2025-08-21 close $166.94 → 2026-08-21 close $239.22
- P/E107.03 as of 2026-08-24
- Net margin+12.2% as of 2026-08-24
- Gross margin+40.3% as of 2026-08-24
- ROE+3.6% as of 2026-08-24
- Debt / equity0.38 as of 2026-08-24
- Revenue growth (YoY)+37.6% as of 2026-08-24
- Revenue CAGR (3y)+22.7% SEC XBRL
- Beta0.76 as of 2026-08-24
- Last reported earnings2026-07-27 SEC EDGAR Form 8-K (Item 2.02)
Dividend: yield +1.2%; at least 5 years of non-decreasing per-share dividends (SEC XBRL) — we do not hold the year before it, so the real streak may be longer.
How WELL compares in its sector
- price-to-earnings ratiotop 25% 127 covered Real Estate peers, as of 2026-08-24
- net profit marginmiddle range 161 covered Real Estate peers, as of 2026-08-24
- operating marginbottom 25% 161 covered Real Estate peers, as of 2026-08-24
- gross marginbottom 25% 156 covered Real Estate peers, as of 2026-08-24
- return on equitymiddle range 162 covered Real Estate peers, as of 2026-08-24
- 3-year revenue CAGRtop 10% 155 covered Real Estate peers
- indicated dividend yieldbottom 10% 138 covered Real Estate peers, as of 2026-08-24
Position among covered Real Estate companies that report each metric (minimum 5 peers). A relative position within our covered catalog — not a valuation, quality, or investment judgment. A higher percentile is simply a higher value (for P/E, more expensive on earnings — never "better"). Informational only.
Top 10 scores & list membership
WELL is not currently in any published Top 10 list. Its scores are below.
Long-term score
56.3 #284 of 987 scored · #18 of 84 in Real Estate
Growth 93rd (revenue growth year over year 37.6%, 3-year revenue CAGR 22.7%) and long-term trend 78th (a "golden cross" — its 50-day average is above its 200-day); weakest is profitability (12th, operating margin 3.6%, return on equity 3.6%).
Short-term score
53.7 #558 of 1,704 scored · #15 of 94 in Real Estate
Volume and participation 81st: it gapped 6.3% above the previous close and has not traded back through the level it left behind — an "unfilled gap", which describes a price range no trade has since crossed and is not a forecast that it will be crossed; trend 68th: a "golden cross" — its 50-day average is above its 200-day; weakest is catalysts 29th: analysts have cut their average price target by 0.0% since the prior reading.
Scores as of 21 Aug 2026. Each bar is a percentile: how this company ranked against every company the score ranked, 0–100. A list is a published formula and its output, not a recommendation. Method version 2.
Dividend coverage (FY2025)
Covered by reported results. In FY2025, WELL's dividend was covered by reported results (operating-cash-flow payout 65%). This describes past coverage, not a forecast.
- Earnings payoutnot assessable earnings not reported
- Operating-cash-flow payout65% dividends / operating cash flow — capital spending was not reported, so this does not subtract it
Coverage derived from reported SEC EDGAR XBRL figures for FY2025 (dividends paid vs. net income and free cash flow, same fiscal year). This describes PAST coverage for one fiscal year — it does not predict whether a dividend will be maintained, raised, or cut, and a one-year payout ratio can be distorted by non-recurring items. Informational only — not financial advice.
How Welltower looks technically
Welltower (WELL) is trading 15.1% above its 200-day average, the long-term trend line — a longer-term uptrend. Its 50-day average crossed above its 200-day average about 859 trading days ago — a "golden cross", a bullish long-term signal. There is no clear trend right now — the price is choppy (ADX, a 0–100 trend-strength gauge, is 15, below the 25 that marks a real trend). Momentum is neutral — its 14-day RSI (a 0–100 momentum gauge) is 56, neither overbought (above 70) nor oversold (below 30). It made a new 20-day low about 9 trading days ago.
Trend
8
| Distance from the 200-day | it is trading 15.1% above its 200-day average, the long-term trend line — a longer-term uptrend | +15.1% |
|---|---|---|
| 50-day moving average | its average price over the last 50 trading days — a short-term trend line — is $231.77 | $231.77 |
| 200-day moving average | its average price over the last 200 trading days — the long-term trend line — is $207.79 | $207.79 |
| Swing structure | each recent peak has been higher than the one before it and each dip has been shallower — the pattern chart-watchers call an uptrend, which describes where price has already been and not where it goes next | higher highs and higher lows |
| Last swing turn | its last significant turn was a swing low 9 calendar days ago — the swings before that are what the structure reading is measured on | 9 sessions |
| Wave structure | its recent swings can be read as a five-part upward sequence — what Elliott-wave chartists call an impulse — now in leg 3 of five; the labelling fails if price closes below 224.97. It is one of several labellings that fit, and it describes the swings already printed, not what comes next. The same swings also read as a three-part correction in leg C. | possible upward five-wave sequence, in wave 3 (one of several readings) |
| Since the 50/200 cross | its 50-day average crossed above its 200-day average about 859 trading days ago — a "golden cross", a bullish long-term signal | 859 sessions |
| Trend strength (14-day ADX) | there is no clear trend right now — the price is choppy (ADX, a 0–100 trend-strength gauge, is 15, below the 25 that marks a real trend) | 14.9 |
Momentum
3
| 14-day RSI | momentum is neutral — its 14-day RSI (a 0–100 momentum gauge) is 56, neither overbought (above 70) nor oversold (below 30) | 56.3 |
|---|---|---|
| Position in its 14-day range | it is trading near the top of its 14-day range ($224.97 to $241.11) — its "stochastic" reading is 88 out of 100, where 0 would mean closing exactly at the 14-session low and 100 exactly at the high. This measures WHERE the price sits inside its recent range, which is a different question from the RSI beside it: RSI is a momentum gauge, measuring how FAST the price has been moving, so a stock can drift quietly to the bottom of its range with an ordinary RSI, or fall sharply and still sit in the middle. It has been climbing within that range over the last few sessions. | 88.3 |
| Since the MACD crossed zero | MACD, a trend-momentum gauge, is in negative territory (momentum leaning bearish) | 18 sessions |
Range
12
| 52-week high | its highest closing price over the past year (about 252 trading days) was $255.20 | $255.20 |
|---|---|---|
| From the 52-week high | it is 6.3% below its 52-week high (its highest price of the past year) | -6.3% |
| Above the 52-week low | it is 48.3% above its 52-week low (its lowest price of the past year) | +48.3% |
| Below the 52-week high | it is 6.3% below its highest point of the past year | 6.3% |
| Since a 20-day breakout | it made a new 20-day low about 9 trading days ago | 9 sessions |
| Since a 55-day breakout | it made a new 55-day high about 21 trading days ago | 21 sessions |
| All-time high | its highest closing price on record is $255.20 (set on 2026-07-28) | $255.20 |
| Given back of the 52-week move | over the past year its closes ranged ($161.88 to $252.07), and it has given back only a small part of its rise from last year’s low — 14% of it. Chart-watchers call 61.8%-65% given back the "golden pocket" — for this company that is $193.45 to $196.33. It is watched widely enough that orders cluster there, which is the honest reason it matters; it is not a forecast. | 14.3% |
| From the all-time high | it is 6.3% below its all-time high | -6.3% |
| Nearest price level | it is trading 7.8% above a support level at $220.63 — a price it turned at twice since 2026-04-29, most recently on 2026-05-13. Since 2024-08-21 it has 15 such levels below the current price and 0 above. Levels like these describe where the price has reversed or paused before; they are not a forecast of where it will go. | -7.8% |
| All-time low | its lowest closing price on record is $24.27 (set on 2020-03-18) | $24.27 |
| Above the all-time low | it is 885.7% above its all-time low | +885.7% |
Volatility
5
| Band width vs its own 6 months | day-to-day price swings are narrower than usual versus its own recent 6-month history (tighter than about 86% of it) | 14th percentile |
|---|---|---|
| Typical daily range | in a typical session it travels about $5.00 between its high and its low — about 2.1% of its price. That is its "average true range" over the last 14 sessions, which also counts the distance from the previous close, so a day that opens well away from yesterday counts as the large move it was | $5.00 |
| Bollinger bands (20-day, ±2σ) | most of its recent trading has stayed between about $226.97 and $245.25 — the "Bollinger bands", a range drawn two standard deviations either side of its 20-day average price, which widens when the stock gets more volatile and narrows when it settles | $226.97 – $236.11 – $245.25 |
| Typical daily range (% of price) | its price moves about 2.1% in a typical session — calmer than most companies we cover. This is the average gap between a session's high and low over the last 14 sessions, counting overnight moves, expressed against the current price so it can be compared with companies trading at any price | 2.1% |
| Stretch from the 200-day average | it is trading 6.3 daily ranges above its 200-day average price (15.1% above it in plain percentage terms) — a way of asking how far it has stretched from its own average in units of how far it normally moves in a day, so a calm company and a jumpy one can be compared on the same scale | 6.3 daily ranges above its 200-day average |
Volume
1
| Volume vs its 30-day average | trading volume is about normal versus its 30-day average | 1.05× |
|---|
Analyst
2
| Change in the average price target | analysts have cut their average price target by 0.0% since the prior reading | -0.0% |
|---|---|---|
| Change in the consensus rating | the analyst consensus rating is unchanged since the prior reading | unchanged |
Candlestick patterns
1
| Since a doji | 3 sessions ago it opened and closed at almost the same price after trading through a wider range — a "doji", the classic picture of buyers and sellers finishing the session level | 3 sessions ago |
|---|
Price gaps
2
| Gap at the open | it opened on 2026-08-21 at essentially the same price it closed at the session before — no meaningful overnight gap | -0.1% |
|---|---|---|
| Open gap | it gapped 6.3% above the previous close 48 sessions ago and has not traded back through the level it left behind at 200 — an "unfilled gap", which describes a price range no trade has since crossed and is not a forecast that it will be crossed | +6.3% |
Price streaks
1
| Closing streak | it has closed higher 4 sessions in a row, a +1.67% move over the run — an unbroken run of up days, which describes what has already happened and says nothing about the next session | 4 sessions up |
|---|
Relative strength
4
| vs market, 1 month | over the past 1 month this stock lagged the market by 5.2 percentage points (the stock lost 2.9% while the market gained 2.3%) | -5.2% |
|---|---|---|
| vs market, 3 months | over the past 3 months this stock beat the market by 7.6 percentage points (the stock gained 10.7% while the market gained 3.1%) | +7.7% |
| vs market, 6 months | over the past 6 months this stock beat the market by 3.8 percentage points (the stock gained 14.9% while the market gained 11.1%) | +3.8% |
| vs market, 12 months | over the past 12 months this stock beat the market by 22.8 percentage points (the stock gained 43.3% while the market gained 20.5%) | +22.8% |
Signal agreement
2
| Bullish technical signals | 4 of the 9 technical signals we can compute for it are currently in a bullish state: a "golden cross" — its 50-day average is above its 200-day, trading above its 200-day average, outperforming the market over 6 months, trading above the Ichimoku cloud — these describe past price behaviour, not a forecast | 4 of 9 |
|---|---|---|
| Bearish technical signals | 2 of the 9 technical signals we can compute for it are currently in a bearish state: MACD momentum is negative, near the top of its 14-day range (overbought) — these describe past price behaviour, not a forecast | 2 of 9 |
Trend (Ichimoku cloud)
1
| Vs the Ichimoku cloud | trading 5.1% above the Ichimoku cloud — a band drawn from where its own highs and lows sat up to 2026-07-16 and projected forward over today's price, the side traders read as an established uptrend, with the band below acting as the level that would have to give way. The band itself is moderate, spanning 3.9% of the share price. | +5.1% |
|---|
Volume-weighted price
2
| Vs this year’s average price paid | the price is 13% above the average price paid so far this year, so the typical buyer over that stretch is showing a gain. That average is $212.34 — a volume-weighted average of daily closes over 155 sessions, not a true tick-by-tick VWAP. | +12.7% |
|---|---|---|
| Vs the average paid since it last reported | the price is 1% above the average price paid since it last reported on 2026-07-27 (its 8-K), so the typical buyer over that stretch is showing a gain. That average is $235.91 — a volume-weighted average of daily closes over 20 sessions, not a true tick-by-tick VWAP. | +1.4% |
Price levels it has turned at before
WELL last closed at $239.22 on 2026-08-21. Since 2024-08-21 it has turned at 15 prices below its last close and 0 above; the 3 nearest below are listed, nearest first.
| Level | Side | Distance | Evidence |
|---|---|---|---|
| $220.63 | Support | 7.8% below the last close | turned there twice · 2026-04-29 to 2026-05-13 |
| $215.32 | Support | 10.0% below the last close | turned there three times · 2026-02-17 to 2026-04-17 |
| $209.83 | Support | 12.3% below the last close | turned there three times · 2025-11-28 to 2026-05-18 |
A level is a price this company reversed or paused at more than once — they describe past behaviour, not a forecast of where the price will go.
Wave structure
Its recent swings can be read as a five-part upward sequence — what Elliott-wave chartists call an impulse — now in leg 3 of five.
This labelling fails — stops being a possible reading at all — if it closes below $224.97.
This is one of several labellings that fit the same swings, so treat it as a reading rather than the reading. It was chosen from 2 labellings that survived the rules, counting shorter readings of the same bars.
On past moves of this shape the leg has usually ended somewhere between $285.50 and $322.91 — that is where it has tended to end if the count holds, not a forecast of where the price goes.
Alternate reading: The same swings also read as a three-part correction in leg C, which fails on a close below $224.97.
This reading has stood for 3 trading days, since 2026-08-19.
Read from daily closes as of 2026-08-21.
An Elliott-wave count describes the swings already printed and the level that would disprove it. It is not a forecast, a target, or advice.
Screens: Trading above the 200-day moving average · trendless / choppy (low ADX) · Stretched far above its 200-day average (6+ daily ranges) · At the top of its 14-day range (stochastic above 80) · Trading above the Ichimoku cloud · Elliott wave 3 candidates | Learn: moving average · golden cross · adx · rsi · breakout
Based on daily closing prices as of 2026-08-21. Describes past price behavior only — informational, not financial advice.
Analyst consensus
- Consensus ratingBuy (1.73 mean, 1=Strong Buy…5=Strong Sell) — 22 analysts
- Mean price target$255.50 range $192.00 – $292.00; median $260.00
Analyst estimates, as of 2026-08-18. These are third-party analyst opinions and price targets, aggregated — not a recommendation, prediction, or advice from stocks-llm. Informational only.
Analyst EPS estimate for WELL
- Consensus EPS estimate$0.61 next reporting period, as of 2026-08-18
Change over time is not available yet: it needs two readings of the same reporting period at least 30 days apart, and we have been recording these estimates since 2026-08-04. An estimate for a DIFFERENT quarter is not a revision, so a reading from before the last report is never compared with one after it.
The consensus estimate for the next reporting period, and how it has moved between readings of that SAME period. A change is measured only between readings estimating one period — when a company reports, the consensus moves to the next quarter and the two numbers are not comparable. Informational only, not a forecast and not advice.
Key risks (from latest filing)
["Regulatory risks related to state licensing, certificate of need (CON) laws, and potential changes in government reimbursement methodologies (Medicare/Medicaid).","Dependence on the financial health and operational success of third-party property operators.","Potential for decreased demand or increased competition in the healthcare facility market, affecting property values and occupancy rates."]
What changed in the latest 10-Q
AI-assisted comparison of WELL's 10-Q filed 2026-04-29 against the prior one filed 2025-10-28.
Management's Discussion & Analysis (MD&A)
- Added:
- Added reference to 'geopolitical tensions or conflicts, such as the ongoing conflict between Russia and Ukraine and in the Middle East' as a forward-looking statement risk factor (filed 2026-04-29)
- Removed:
- Removed specific reference to 'COVID-19 pandemic' example in health emergencies risk factor; now states generic 'public health emergencies' (filed 2025-10-28 had this specificity)
- Reworded:
- Changed 'health emergencies (such as the COVID-19 pandemic)' to 'public health emergencies' (filed 2026-04-29)
- Changed reference document from 'Annual Report on Form 10-K for the year ended December 31, 2024' to 'Annual Report on Form 10-K for the year ended December 31, 2025' (filed 2026-04-29)
- Changed 'our consolidated financial statements' to 'our unaudited consolidated financial statements' (filed 2026-04-29)
- Changed 'Pounds Sterling' to 'British Pounds Sterling' (filed 2026-04-29)
- Changed 'is reflected at fair value' to 'are reflected at fair value' (filed 2026-04-29)
- Changed 'the United Kingdom' to 'the U.K.' (filed 2026-04-29)
- Notes:
- The newer filing shows updated financial data tables with dates changed from September 30, 2025 and December 31, 2024 to March 31, 2026 and December 31, 2025, with corresponding updated principal balances and fair value figures
- Variable rate debt amounts changed from $2,055,045,000 (Sept 30, 2025) to $2,866,865,000 (March 31, 2026)
- The text in both filings appears truncated at the end, preventing full comparison of the currency fluctuation discussion section
Risk Factors
The two filings could not be meaningfully compared for this section.
AI-assisted comparison of two SEC filing sections. It describes wording and theme changes only, makes no materiality, legal, or investment judgement, and is not financial advice. Informational only — not financial advice.
Insider activity (SEC Form 4)
No open-market insider purchases or sales are on record for WELL — recent Form 4 activity was compensation-related (awards, option exercises, or tax withholding), not open-market buying or selling.
View full insider trading history → View SEC Form 3/4/5 filingsOnly open-market purchases (SEC code P) and sales (code S) are counted here. Option exercises, vesting/awards, gifts, and shares withheld for taxes are excluded — they are compensation or mechanical, not open-market conviction. Sales may be planned and non-discretionary (e.g. a Rule 10b5-1 plan) and are not necessarily bearish; open-market buying is not a recommendation to buy. Informational only — not financial advice.
Congressional trading disclosures
U.S. House members publicly disclose their own, their spouse's, and dependent children's stock transactions under the STOCK Act. We hold 2 matched disclosures for WELL from U.S. House Clerk Periodic Transaction Report filings.
Congressional trading disclosures →Short interest (FINRA)
WELL had 17,696,568 shares of reported short interest as of the 2026-07-31 FINRA settlement date (delayed, bi-monthly; not real-time).
WELL had 2.51% of its shares outstanding sold short as of the 2026-07-31 FINRA settlement date (percent of FLOAT would be higher — float is not disclosed in the source). FINRA reported 5.92 days to cover at the same settlement.
- Reported short interest (shares) 17,696,568
- Short interest (% of shares outstanding) 2.51%
- Prior settlement (shares) 19,065,952
- Reported change -7.18%
- Days to cover (reported) 5.92
Reported to FINRA as of the 2026-07-31 settlement date. Short interest is reported to FINRA and published on a delayed, bi-monthly schedule (as of a settlement date, disseminated roughly eight business days later) — it is NOT real-time, does not cover every venue or all US trading, and is not a short-squeeze prediction or investment advice. Days-to-cover is the value FINRA reports; percent of float is not shown because the source file carries no share-count denominator — where a percent appears it is of shares OUTSTANDING, the larger base, and is therefore a floor on percent of float. Informational only — not financial advice.
Competitors & peers
- Ventas (VTR)
- Healthpeak Properties
- Sabra Health Care REIT (SBRA)
- Omega Healthcare Investors (OHI)
- National Health Investors (NHI)
AI-enriched competitor set. Linked names are companies covered by stocks-llm; other named peers are shown for reference only.
Compare WELL vs…
Welltower is found in…
WELL shows up in…
Frequently asked questions
What does Welltower (WELL) do?
Welltower is a real estate investment trust (REIT) that invests in healthcare infrastructure, specifically focusing on seniors housing, post-acute care, and outpatient medical properties. The company operates through a portfolio of properties that are managed by third-party operators or through RIDEA-structured arrangements, providing a range of care levels from independent living to skilled nursing.
What sector is Welltower (WELL) in?
Welltower (WELL) is classified in the Real Estate sector. Its industry is Healthcare REIT. It trades on NYSE.
Does WELL pay a dividend?
Yes — Welltower (WELL) pays a dividend, with an indicated yield of about 1.21% and at least 5 years of non-decreasing per-share dividends (SEC EDGAR XBRL) — we do not hold the year before it, so the real streak may be longer (market data, as of 2026-08-24). Informational only — not financial advice.
Who are Welltower's (WELL) competitors?
Notable peers of Welltower (WELL) include Ventas, Healthpeak Properties, Sabra Health Care REIT, Omega Healthcare Investors and National Health Investors. This peer set is informational only — not financial advice.
Has there been recent Congressional stock trading in WELL?
Yes — we hold 2 matched STOCK Act disclosures for WELL from U.S. House Clerk Periodic Transaction Report filings. These are legally-required disclosures (often filed 30–45 days after the trade), may belong to a U.S. House member, their spouse, or a dependent child, and are not an indicator of company performance or investment advice.
Is Welltower (WELL) overbought or oversold right now?
Welltower (WELL) is currently neither overbought nor oversold — its 14-day RSI (a 0–100 momentum gauge) is 56, in the neutral middle (as of 2026-08-21). RSI describes recent price momentum, not a forecast — informational only, not financial advice.
Where does stocks-llm's data on WELL come from?
Fundamentals and prices come from market data, as of 2026-08-24; company filings and profile facts come from SEC EDGAR. All figures are delayed daily-close data shown with their as-of date — informational only, not financial advice.
Fundamentals: market data, as of 2026-08-24. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-08-21.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & market data, shown with their as-of date.